Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change.

International journal of cancer·2026
Same author

Future of population-based cancer registries: A global perspective-A survey of population-based cancer registries.

International journal of cancer·2025
Same author

Remote Monitoring and Data Collection for Decentralized Clinical Trials.

JAMA network open·2024
Same author

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.

European urology·2023
Same author

ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models.

Molecular cancer therapeutics·2021
Same author

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.

European urology·2021

Related Experiment Video

Updated: Jun 22, 2026

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Predictive modeling in prostate cancer. Conclusions and reflections.

Louis J Denis1, Mary K Gospodarowicz

  • 1Oncologic Centre Antwerp, Antwerp, Belgium. louis.denis@skynet.be

Cancer
|June 23, 2009
PubMed
Summary

Validated prognostic factors aid cancer diagnosis, but mathematical models provide group, not individual, outcome predictions. Host and environmental factors are crucial for personalized cancer prognosis and treatment decisions.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Oncology
  • Biostatistics
  • Cancer Research

Background:

  • Validated prognostic factors are essential for accurate cancer diagnosis and treatment planning.
  • The increasing number of novel markers and clinical trial data complicates treatment decision-making.
  • Current prognostic tools often stratify outcomes for patient groups, not individuals.

Purpose of the Study:

  • To highlight the limitations of current prognostic models in cancer care.
  • To emphasize the need for a holistic approach considering individual patient factors.
  • To advocate for the evaluation of host and environmental influences in tumor prognosis.

Main Methods:

  • Review of existing prognostic factors and mathematical modeling techniques (nomograms).
  • Analysis of the predictive accuracy of nomograms in different disease phases.
  • Discussion of the implications of group-based outcome stratification versus individual patient needs.

Main Results:

  • Advanced mathematical models (nomograms) are developed to predict outcomes based on prognostic factors.
  • These models offer specific predictive accuracy but stratify results for groups.
  • The study underscores that current models do not provide individual patient-level predictions.

Conclusions:

  • Prognostic factor evaluation is integral to cancer diagnosis and treatment.
  • Mathematical models offer valuable insights but do not replace comprehensive patient assessment.
  • Host and environmental factors must be evaluated for informed clinical decisions in cancer prognosis.